Oncology & Cancer

Study examines drug resistance in ALK positive lung cancer

Scientists from the University of Colorado Cancer Center have once again advanced the treatment of a specific kind of lung cancer. The team has documented how anaplastic lymphoma kinase (ALK) positive advanced non-small cell ...

Oncology & Cancer

The link between TB and a gene mutation that causes lung cancer

Tuberculosis (TB) has been suspected to increase a person's risk of lung cancer because the pulmonary inflammation and fibrosis can induce genetic damage. However, direct evidence of specific genetic changes and the disease ...

Oncology & Cancer

Accelerated radiotherapy more efficient than current practice

Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer (NSCLC). But, until now, researchers had not looked at the cost-effectiveness of the ...

Oncology & Cancer

Need for national Canadian strategy for EGFR testing

Significant advances have taken place in the management of patients with advanced and metastatic non–small-cell lung cancer (NSCLC) over the last 5 years. Traditionally, all advanced NSCLC patients were treated in a similar ...

Oncology & Cancer

Researchers use immunocytochemistry to determine ALK status

Personalized medicine in lung cancer relies on the identification and characterization of cancer biomarkers and the availability of accurate detection systems and therapies for those biomarkers. The standard procedure for ...

Oncology & Cancer

Study shows SBRT for stage I NSCLC safe and effective

Stereotactic body radiotherapy (SBRT) is considered the treatment of choice for early-stage non–small-cell lung cancer (NSCLC) if patients are inoperable because of additional medical conditions. This is based on several ...

page 8 from 14